- ProShares UltraPro Short QQQ, CoreWeave, Inc. Class A Common Stock, and Intra-Cellular Therapies are highlighted as key value stocks to monitor, based on their recent trading volumes.
- ProShares UltraPro Short QQQ aims for three times the inverse of the NASDAQ-100 Index's daily performance, while CoreWeave focuses on AI infrastructure, and Intra-Cellular Therapies develops drugs for neuropsychiatric disorders.
- These stocks have shown significant trading activity, with ProShares SQQQ trading at $36.91, CoreWeave at $54.66, and Intra-Cellular Therapies at $131.91 during recent sessions.
- MarketBeat highlights Intra-Cellular Therapies, Eli Lilly, and Walmart as key medical stocks to monitor due to their high trading volumes.
- Intra-Cellular Therapies focuses on neuropsychiatric drug development, while Eli Lilly offers a range of diabetes and obesity medications, and Walmart operates a vast retail and eCommerce network.
- Each company shows significant market activity, with varying stock performance metrics, indicating their importance in the healthcare and retail sectors.
